In January 2005 Australia implemented the Australia? United States Free Trade Agreement (AUSFTA). The agreement had placed domestic health policy and the Pharmaceutical Benefits Scheme (PBS) in particular, on the trade negotiating table. At the time Australians were told the PBS would not be undermined, but why was it included in a trade agreement? This article argues that recent reforms to the PBS partially delivered on an issue that the US has compelled its trade negotiators to ensure since 2002: the elimination of reference pricing. In Australia, reference pricing, as used by the PBS, had been credited with obtaining money when buying new medicines
A little-noticed provision of the Australia-US Free Trade Agreement could prove to be a nasty surpri...
Much of the rhetoric that underpins arguments for free trade relies on the assertion that free tra...
This paper examines the recent UK House of Commons Health Committee report on the Influence of the P...
This paper considers the likely impact of reforms sought by the US pharmaceutical companies on the P...
Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of nego...
With the third round of trade negotiations currently underway, this paper explores possible conseque...
Research Doctorate - Doctor of Philosophy (PhD)In January 2005 Australia implemented the Australia-U...
On 1 January 2005, a controversial trade agreement entered into force between Australia and the Unit...
Providing access to affordable medicines and rewarding innovation produces a difficult tension in th...
This Case Study examines, with particular reference to the Australian Pharmaceutical Benefits Scheme...
Much of the debate over the Australia-US Free Trade Agreement centres on whether and how it will aff...
Australia did poorly in several key areas of the recently completed free trade agreement with the US...
Australia did poorly in several key areas of the recently completed free trade agreement with the US...
ABSTRACT Australia did poorly in several key areas of the recently completed free trade agree-ment w...
The Australia-U.S. Free Trade Agreement (AUSFTA), which entered into force on January 1, 2005, conta...
A little-noticed provision of the Australia-US Free Trade Agreement could prove to be a nasty surpri...
Much of the rhetoric that underpins arguments for free trade relies on the assertion that free tra...
This paper examines the recent UK House of Commons Health Committee report on the Influence of the P...
This paper considers the likely impact of reforms sought by the US pharmaceutical companies on the P...
Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of nego...
With the third round of trade negotiations currently underway, this paper explores possible conseque...
Research Doctorate - Doctor of Philosophy (PhD)In January 2005 Australia implemented the Australia-U...
On 1 January 2005, a controversial trade agreement entered into force between Australia and the Unit...
Providing access to affordable medicines and rewarding innovation produces a difficult tension in th...
This Case Study examines, with particular reference to the Australian Pharmaceutical Benefits Scheme...
Much of the debate over the Australia-US Free Trade Agreement centres on whether and how it will aff...
Australia did poorly in several key areas of the recently completed free trade agreement with the US...
Australia did poorly in several key areas of the recently completed free trade agreement with the US...
ABSTRACT Australia did poorly in several key areas of the recently completed free trade agree-ment w...
The Australia-U.S. Free Trade Agreement (AUSFTA), which entered into force on January 1, 2005, conta...
A little-noticed provision of the Australia-US Free Trade Agreement could prove to be a nasty surpri...
Much of the rhetoric that underpins arguments for free trade relies on the assertion that free tra...
This paper examines the recent UK House of Commons Health Committee report on the Influence of the P...